Acute exacerbations in patients with idiopathic pulmonary fibrosis. - Wikidata - awgldk - TriplyDB

Acute exacerbations in patients with idiopathic pulmonary fibrosis.

Acute exacerbations in patients with idiopathic pulmonary fibrosis.

http://www.wikidata.org/entity/Q37152742

about

Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis Mesenchymal stem cells in the treatment of chronic lung disease Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis.Atorvastatin attenuates bleomycin-induced pulmonary fibrosis via suppressing iNOS expression and the CTGF (CCN2)/ERK signaling pathway.Diagnosis and management of interstitial lung disease.Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries Bone marrow mesenchymal stem cells protect against bleomycin-induced pulmonary fibrosis in rat by activating Nrf2 signaling.Novel Therapeutic Strategies for Reducing Right Heart Failure Associated Mortality in Fibrotic Lung Diseases.

P2860

Q26783169-6DD52819-C5FC-42B0-99EA-DC8467595E33 Q28079373-82F4BFCA-3A7F-4C0B-85DE-F6644B96F7D0 Q34973462-E2272962-3473-48A9-AE20-031E7C83BBC9 Q37421028-FBCCCDD9-1A61-4023-8E77-B8DC4E529FEC Q38288028-87A893A2-ABA8-44FB-979F-7AEF75512B4D Q41712176-D191A7C0-DE33-4C52-9E78-865109F88242 Q41812311-3018462F-D957-4A87-A27D-28E4B49D46E0 Q43184339-23EDBB74-704A-4768-8B93-F7B7045DABAB

P2860

Acute exacerbations in patients with idiopathic pulmonary fibrosis.

http://www.wikidata.org/entity/Q37152742

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Acute exacerbations in patients with idiopathic pulmonary fibrosis.

@en

Acute exacerbations in patients with idiopathic pulmonary fibrosis.

@nl

type

label

Acute exacerbations in patients with idiopathic pulmonary fibrosis.

@en

Acute exacerbations in patients with idiopathic pulmonary fibrosis.

@nl

prefLabel

Acute exacerbations in patients with idiopathic pulmonary fibrosis.

@en

Acute exacerbations in patients with idiopathic pulmonary fibrosis.

@nl

P1433

Q37152742-B18D8CAC-15E7-4215-BCA4-C24E4B2591DE

P1476

Q37152742-10E34D33-F18C-48A8-BD7C-41602592B6E6

P2093

Q37152742-29E655F8-5003-4528-AFD0-009DC8641878

P2860

Q37152742-046BA9E9-4A4C-4F81-8661-0B074731E8B8

Q37152742-082D31CE-01FD-4B2F-8F87-3A9A8ADEAC37

Q37152742-0D31633F-E63E-45FE-8A8A-EE36BAF51B2F

Q37152742-0D5E3487-0840-4265-BA87-A0E023858678

Q37152742-1BBD9FC9-3530-48FF-9333-AF8D2043B4EE

Q37152742-1F03B1CE-6F40-4AF7-99A5-EF6E0ADB300D

Q37152742-21DE5CA6-6A30-452C-8DDB-0CA385591186

Q37152742-23DAB376-81C0-4039-8020-06FE4D080122

Q37152742-24C5B50A-7C1F-4892-A287-341737E8D846

Q37152742-280857A2-0F54-4DF5-8742-BB87CA5C8FD5

P2888

Q37152742-A05E04D8-8ADC-4241-A857-F30480B78AFD

P304

Q37152742-96372E1E-28EA-4543-8D2D-ED19550AE320

P31

Q37152742-33EDB349-742C-4DC8-A772-A36E12DA870F

P356

Q37152742-839D43EF-9765-44E3-808F-278C18013415

P478

Q37152742-7F9FE71D-8422-4149-81FC-A92CA41771E0

P577

Q37152742-68DDABCB-A779-40FF-B3E7-2C8D1C38FEEB

P5875

Q37152742-5B9C4B54-A44F-4174-AFFB-906FB0DA97B7

P6179

Q37152742-BCEAD495-166B-4F00-917F-E4F62A9B6339

P698

Q37152742-6947AAD2-7891-4FD1-B412-72FF30D6D700

P921

Q37152742-40CE5E7C-A156-4202-95C6-69C34869F779

P932

Q37152742-DE024CA0-39D7-467C-AA4D-79DA87A47925

P356

1465-9921-14-86

P1433

Respiratory Research

P1476

Acute exacerbations in patients with idiopathic pulmonary fibrosis.

@en

P2093

Dong Soon Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3

Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis

Classification and natural history of the idiopathic interstitial pneumonias

Acute exacerbation of IPF following diagnostic bronchoalveolar lavage procedures

Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature

Viruses as co-factors for the initiation or exacerbation of lung fibrosis

BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy

Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

P2888

1465-9921-14-86

P304

86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1465-9921-14-86

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256075518

http://www.w3.org/2001/XMLSchema#string

P6179

1027485871

http://www.w3.org/2001/XMLSchema#string

P698

23964926

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

3765544

http://www.w3.org/2001/XMLSchema#string